Nanovaccines utilize nanoparticles to deliver antigens in a manner that mimics natural infection, thereby inducing a stronger and more durable immune response. This can lead to improved vaccine efficacy and reduced dosing requirements. Nanovaccines are particularly promising for diseases where traditional vaccines have been less effective, such as HIV and certain types of influenza.
